Benjamin Rix Brooks

12PUBLICATIONS
12CO-AUTHORS
Pharmaceutical delivery technologiesLiquid biopsiesMedical genetics (excl. cancer genetics)Predictive and prognostic markersMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 07, 2026
Generalizability of Edaravone Efficacy.

Benjamin Rix Brooks, David L Ennist, Danielle Beaulieu

|Feb 07, 2026
Survival of Intravenous Edaravone-Treated Patients With ALS: Evidence From Administrative Claims Analyses.

Benjamin Rix Brooks, James D Berry, Malgorzata Ciepielewska

|Feb 07, 2026
Study 19 (MCI186-19) Post Hoc Analyses.

Benjamin Rix Brooks, Jeremy Shefner, Stephen Apple

|May 22, 2024
Letter to the Editor: Glycemic Index/Load Effect on Amyotrophic Lateral Sclerosis Progression: Potential Interaction with Riluzole.

Benjamin Rix Brooks

|Aug 01, 2023
The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosis.

Benjamin Rix Brooks, Erik P Pioro, Takeshi Sakata

|Jul 31, 2023
Amyotrophic Lateral Sclerosis Quality Measurement Set 2022 Update: Quality Improvement in Neurology.

Kathryn A Kvam, Michael Benatar, Alisa Brownlee

Pageof 2

Frequent Collaborators

4 joint publications

Stephen Apple

3 joint publications

Erik P Pioro

2 joint publications

Björn Oskarsson

1 joint publications

Nicholas Maragakis